I
Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology.
Investor insights
Funding rounds participated in
$126M sweet spot round size
Investor type
Public Company
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2012
Funding rounds raised
Total raised
$126M
from 3 investors over 1 rounds
I
Inventiva Pharma raised $126M on November 14, 2024
Investors: New Enterprise Associates, Biotechnology Value Fund and + 9 Other investors